Affiliation:
1. Department of Gastrointestinal Surgery, Ibaraki Prefectural Central Hospital, Kasama City, Japan.
2. Department of Surgery, National Defense Medical College Hospital, Tokorozawa
Abstract
Objective
The aim of the study is to evaluate the influence of cachexia at the time of diagnosis of pancreatic ductal adenocarcinoma (PDAC) on prognosis in patients undergoing surgical resection.
Methods
Patients with data on preoperative body weight (BW) change followed by surgical resection during 2008–2017 were selected. Large BW loss was defined as weight loss >5% or >2% in individuals with body mass index less than 20 kg/m2 within 1 year preoperatively. Influence of large BW loss, ΔBW defined as preoperative BW change (%) per month, prognostic nutrition index, and indices of sarcopenia.
Results
We evaluated 165 patients with PDAC. Preoperatively, 78 patients were categorized as having large BW loss. ΔBW was ≤ −1.34% per month (rapid) and > −1.34% per month (slow) in 95 and 70 patients, respectively. The median postoperative overall survival of rapid and slow ΔBW groups was 1.4 and 4.4 years, respectively (P < 0.001). In multivariate analyses rapid ΔBW (hazard ratio [HR], 3.88); intraoperative blood loss ≥430 mL (HR, 1.89); tumor size ≥2.9 cm (HR, 1.74); and R1/2 resection (HR, 1.77) were independent predictors of worse survival.
Conclusions
Preoperative rapid BW loss ≥1.34% per month was an independent predictor of worse survival of patients with PDAC.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献